
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Agmatine sulfate is a metabolite of L-arginine that modulates NMDA receptors and nitric oxide synthase pathways in the brain. This amino acid derivative supports cognitive function, mood regulation, and neuroprotection through its actions on neurotransmitter systems.

Reported Benefits (Provisional)
Origin & History

Agmatine sulfate is a naturally occurring compound derived from the amino acid arginine. It is produced through a decarboxylation process, resulting in a stable form used in dietary supplements.
Research Narrative (Provisional)
Preliminary studies, including in vitro and animal research, suggest agmatine's potential in neuroprotection and pain management. Human trials are limited but promising.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Derived from arginine, contains no calories, fats, or carbohydrates. - Available in doses ranging from 500 mg to 2 g. - Acts as a neurotransmitter and neuromodulator.
Reported Mechanism (Provisional)
Agmatine sulfate acts as an endogenous ligand for imidazoline receptors and blocks NMDA receptors, particularly at the polyamine binding site. It inhibits nitric oxide synthase enzymes and modulates calcium channels, affecting neurotransmitter release. The compound also influences serotonin, norepinephrine, and dopamine pathways through its interaction with monoamine oxidase and various receptor subtypes.
Clinical Narrative (Provisional)
Human studies on agmatine sulfate are limited, with most evidence coming from animal models and small-scale trials. A pilot study of 13 depression patients showed mood improvements with 2-3g daily dosing over 3 weeks. Rodent studies demonstrate neuroprotective effects and enhanced learning at doses of 10-100 mg/kg. The clinical evidence remains preliminary, requiring larger randomized controlled trials to establish therapeutic efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







